Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder

Physiology and Behavior

Volumn 87, Issue 5, 2006, Pages 881-890

  Harvey, Brian H ^a   Brand, Linda ^a   Jeeva, Zakkiyya ^a   Stein, Dan J ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Anxiety; Cortex; Corticosterone; Halothane; Hippocampus; Monoamines; PTSD; Stress

Indexed keywords

CORTICOSTERONE; DOPAMINE; HALOTHANE; MONOAMINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOPAMINE BRAIN LEVEL; EVOKED SOMATOSENSORY RESPONSE; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALADJUSTMENT; MALE; MONOAMINERGIC SYSTEM; NEUROBIOLOGY; NONHUMAN; NORADRENALIN BRAIN LEVEL; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; STATISTICAL SIGNIFICANCE; STRESS;

EID: 33646121520     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2006.01.033     Document Type: Article

References (68)

1. Heuser I., and Lammers C.L. Stress and the brain. Neurobiol Aging 24 (2003) S69-S76
2. Munck A., Guyre P.M., and Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5 (1984) 25-44
3. De Kloet E.R. Hormones, brain and stress. Endocr Regul 37 (2003) 51-68
4. De Kloet E.R., Joels M., and Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6 (2005) 463-475
5. McEwen B.S. Protective and damaging effects of stress mediators: the good and bad sides of the response to stress. J Clin Endocrinol Metab 51 (2002) 2-4
6. McEwen B.S. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci 1032 (2004) 1-7
7. American Psychatric Association (APA). Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. (1994) Washington, DC
8. Newport D.J., and Nemeroff C.B. Neurobiology of posttraumatic stress disorder. Curr Opin Neurobiol 10 (2000) 211-218
9. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K., et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 156 (1999) 585-588
10. Liberzon I., Lopez F., and Flagel S.B. Differential regulation of hippocampal glucocorticoid receptor mRNA and fast feedback: relevance to post-traumatic stress disorder. Neuroendocrinology 11 (1999) 11-17
11. Yehuda R., Bierer L.M., Schmeidler J., Aferiat D.H., Breslau I., and Dolan S. Low cortisol and risk for PTSD in adult offspring of Holocaust survivors. Am J Psychiatry 157 (2000) 1252-1259
12. Yehuda R. Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder. In: Yehuda R., and McFarlane A.C. (Eds). Psychobiology of Posttraumatic Stress Disorder (1997), The New York Academy of Sciences, New York 57-75
13. Yehuda R., and Harvey H. Relevance of neuroendocrine alterations in PTSD to cognitive impairments of trauma survivors. In: Read D., and Lindsay S. (Eds). Recollections of trauma: scientific research and clinical practice (1997), Plenum Press, New York 221-252
14. Stein D.J., Zungu-Dirwayi N., van Der Linden G.J., and Seedat S. Pharmacotherapy for posttraumatic stress disorder. Cochrane Database Syst Rev 4 (2000) CD002795
15. Harvey B.H. The neurobiology and pharmacology of depression. S Afr Med J 87 (1997) 540-550
16. Connor K.M., and Davidson J.R.T. The role of serotonin in posttraumatic stress disorder: neurobiology and pharmacotherapy. CNS Spectr 3 (1998) 43-51
17. Cassano W.J., and D'Mello A.P. Acute stress-induced facilitation of the hypothalamic-pituitary-adrenal axis: evidence for the roles of stressor duration and serotonin. Neuroendocrinology 74 (2001) 167-177
18. Weidenfeld J., Newman M.E., Itzik A., Gur E., and Feldman S. The amygdala regulates the pituitary-adrenocortical response and release of hypothalamic serotonin following electrical stimulation of the dorsal raphe nucleus in the rat. Neuroendocrinology 76 (2002) 63-69
19. Leonard B.E. Fundamentals of Psychopharmacology. 3rd ed. (2003), John Wiley and Sons, Chichester, UK
20. Heimrick-Leuke S., and Evans D.C. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis. Neuropharmacology 42 (2002) 162-169
21. Kirby L.G., Allen A.R., and Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 682 (1995) 189-196
22. Kirby L.G., Chou-Green J.M., Davis K., and Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 760 (1997) 218-230
23. Kirby L.G., and Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther 282 (1997) 967-976
24. Kirby L.G., and Lucki I. The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat. Stress 2 (1998) 251-263
25. Stanford S.C. Central noradrenergic neurones and stress. Pharmacol Ther 68 (1995) 297-342
26. Pezze M.A., and Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 74 (2004) 301-320
27. Koob G.F. Corticotropin-releasing factor, norepinephrine and stress. Biol Psychiatry 46 (1999) 1176-1180
28. Nemeroff C.B., Bremner J.D., Foa E.B., Mayberg H.S., North C.S., and Stein M.B. Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res 40 (2006) 1-21
29. Debeic J., and Ledoux J.E. Disruption of reconsolidation but not consolidation of auditory fear conditioning by adrenergic blockade in the amygdala. Neuroscience (2004) 267-272
30. Nisenbaum L.K., and Abercrombie E.D. Enhanced tyrosine hydroxylation in hippocampus of chonically stressed rats upon exposure to a novel stressor. J Neurochem 58 (1992) 276-281
31. Rosario L.A., and Abercrombie E.D. Individual differences in behavioural reactivity: correlation with stress-induced nor-epinephrine efflux in the hippocampus of Sprague-Dawley rats. Brain Res Bull 48 (1999) 595-602
32. Finlay J.M., Zigmond M.J., and Abercrombie E.D. Increased dopamine and norepinephrine release in medial pre-frontal cortex induced by acute and chronic stress: effects of diazepam. Neurosci 64 (1995) 619-628
33. Sullivan G.M., Coplan J.D., Kent J.M., and Gorman J.M. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 46 (1999) 1205-1218
34. Dazzi L., Spiga F., Pira L., Ladu S., Vacca G., Rivano A., et al. Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs. J Neurochem 76 (2001) 1212-1220
35. Pawlak R., Takada Y., Takahashi H., Urano T., Nagai N., and Takada A. Differential effects of nicotine against stress-induced changes in dopaminergic system in rat striatum and hippocampus. Eur J Pharmacol 387 (2000) 171-177
36. Zhang X., Kindel G.H., Wulfert E., and Hanin I. Effects of immobilisation stress on hippocampal monoamine release: modification by mivazerol, a new alpha-2-adrenoceptor agonist. Neuropharmacology 34 (1995) 1661-1672
37. Yamato T., Yamasaki S., Misumi Y., Kino M., Obata T., and Aomine M. Modulation of the stress response by coffee: an in vivo microdialysis study of hippocampal serotonin and dopamine levels in rat. Neurosci Lett 332 (2002) 87-90
38. Morrow B.A., Elsworth J.D., Rasmusson A.M., and Roth R.H. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 92 (1999) 553-564
39. Pani L., Porcella A., and Gessa G.L. The role of stress in the pathophysiology of the dopaminergic system. Mol Pharmacol 5 (2000) 14-21
40. Seamans J.K., and Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74 (2004) 1-58
41. Yehuda R., Southwick S., Giller E.L., Ma X., and Mason J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis 180 (1992) 321-325
42. Uys J.D.K., Stein D.J., Daniels W.M.U., and Harvey B.H. Animal models of anxiety disorders. Curr Psychiatry Rep 5 (2003) 274-281
43. Herman J.P., and Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20 (1997) 78-84
44. Johnsen B.H., Eid J., Laberg J.C., and Thayer J.F. The effect of sensitization and coping style on posttraumatic stress symptoms and quality of life. Scand J Psychol 43 (2002) 181-188
45. Yehuda R., and Antelman S.M. Criteria for rationally evaluating animal models of posttraumatic stress disorder. Biol Psychiatry 33 (1993) 479-486
46. Liberzon I., Krstov M., and Young E.A. Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology 22 (1997) 443-453
47. Khan S., and Liberzon I. Topiramate attenuates exaggerated acoustic startle in an animal model of posttraumatic stress disorder. Psychopharmacology 172 (2004) 225-229
48. 1A/2A receptor changes evoked by a time-dependent sensitisation (TDS) stress model in rats. Brain Res 983 (2003) 97-107
49. Harvey B.H., Naciti C., Brand L., and Stein D.J. Serotonin and stress: protective or malevolent actions in the biobehavioural response to repeated trauma. Ann N Y Acad Sci 1032 (2004) 267-272
50. Maes M., Mylle J., Delmeire L., and Janca A. Pre- and post-disaster negative life events in relation to the incidence and severity of post-traumatic stress disorder. Psychiatry Res 105 (2001) 1-12
51. 2O or sham anaesthesia. Lab Anim 36 (2002) 105-114
52. Pashkov V.N., and Hemmings Jr. H.C. The effects of genertal anaesthetics on norepinephrine release from isolated rat cortical nerve terminals. Anaesth Analg 95 (2002) 1274-1281
53. Toner C.C., Milne A.J., Blatchford K.L., McLaughlin D.P., and Stamford J.A. An assessment of the cerebroprotective potential of volatile anaesthetics using two independent methods in an in vitro model of cerebral ischaemia. Brain Res 958 (2002) 390-398
54. Baumans V. Assessment of pain and discomfort in laboratory animals. In: Pain Research and assessment of pain and distress in laboratory animals. Proceedings of the international joint meeting twelfth ICLAS general assembly and conference seventh FELASA symposium, Palma de Mallorca, Spain 1999. www.secal.es/word-pdf/felasa99.pdf. Date of access: 2 September 2005.
55. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 140-167
56. Harvey B.H., Oosthuizen F., Wegener G., and Stein D.J. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology 175 (2004) 494-502
57. Ledoux J. Fear and the brain: where are we and where are we going?. Biol Psychiatry 44 (1998) 1229-1238
58. Cenzi M.A., Kalen P., Mandel R.J., and Bjorkland A. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate putamen: amicrodialysis study in the rat. Brain Res 581 (1992) 217-228
59. Rossetti Z.L., Portas C., Pani L., Carboni S., and Gessa G.L. Stress increases noradrenaline release in the rat frontal cortex: prevention by diazepam. Eur J Pharmacol 176 (1990) 229-231
60. Glover D.A., Powers M.B., Bergman L., Smits J.A.J., Telch M.J., and Stuber M. Urinary dopamine and turn bias in traumatised women with and without PTSD symptoms. Behav Brain Res 144 (2003) 137-141
61. Jezova D., Makatsori A., Duncko R., Moncek F., and Jakubek M. High trait anxiety in healthy subjects is associated with low neuroendocrine activity during psychological stress. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 1331-1336
62. Thomas M.J., Moody T.D., Makhinson M., and O'Dell T.J. Activity-dependent beta-adrenergic modulation of low-frequency stimulation induced LTP in the hippocampal CA1 region. Neuron 17 (1996) 475-482
63. Torres I.L., Gamaro G.D., Vasconcelles A.P., Silveira R., and Dalmaz C. Effects of chronic restraint stress on feeding behaviour and on monoamine levels in different brain structures in rats. Neurochem Res 27 (2002) 519-525
64. Spivak B., Vered Y., Graff E., Blum I., Mester R., and Weizman A. Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder. Biol Psychiatry 45 (1999) 840-845
65. Segman R.H., Cooper-Kazaz R., Macciardi F., Goltser T., Halfon Y., and Dobroborski T. Association between the dopamine transporter gene and posttraumatic stress disorder. Mol Psychiatry 7 (2002) 903-907
66. Mason J.W., Wang S., Yehuda R., Lubin H., Johnson D., and Bremner J.D. Marked lability in urinary cortisol levels in subgroups of combat veterans with posttraumatic stress disorder during an intensive exposure treatment program. Psychosom Med 64 (2002) 238-246
67. Schelling G., Kilger E., Roozendaal B., de Quervain D.J.-F., Briegel J., Dagge A., et al. Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study. Biol Psychiatry 55 (2004) 627-633
68. Brand L., Naciti C., Stein D.J., and Harvey B.H. Cognitive dysfunction and serotonin receptor changes evoked by stress-restress are reversed by the steroid synthesis inhibitor, ketoconazole. Int J Neuropsychopharmacol 7 suppl 1 (2004) S459 (published abstract)